AliveDx Suisse S.A. and Disera Tibbi Malzeme Lojistik. san. Tic. A.S have signed a distribution agreement, which will enable Disera to distribute the MosaiQ® and LumiQ™ solutions in Türkiye. The distribution agreement takes effect immediately. This strategic partnership with an

AliveDx Suisse S.A. and Vital Care Prod SPA have signed a distribution agreement, which will enable Vital Care to distribute the MosaiQ® and LumiQ™ solutions in Algeria. The distribution agreement takes effect immediately. This partnership underscores AliveDx’s dedication to broadening

Alba Bioscience Limited and Medline Industries, LP have signed a distribution agreement, which will enable Medline to distribute Alba’s range of reagents in the USA. The distribution agreement takes effect immediately. Alba develops and manufactures high-quality blood bank reagents for

Are you facing challenges in achieving accurate, timely diagnoses for patients with suspected autoimmune conditions? Join us for an exclusive webinar where Dr. Gerber Gomez, Scientific & Medical Officer at AliveDx, will share: Date: 13 March 2025 Time: 14h00-15h00 CET

We are excited to announce that our MosaiQ AiPlex® Celiac Disease (CD) solution has obtained Medical Device Authority (MDA) registration in Malaysia! The registration confirms the safety, quality, and effectiveness of our system. With this approval, AliveDx is now authorized

Alba Bioscience is pleased to have completed the UK National Health Service (NHS) Evergreen Sustainable Supplier Assessment. The Assessment is a self-assessment and reporting tool and resulted in Alba Bioscience receiving a Level 2: Comprehensive net zero targets and reporting